Amgen (AMGN -0.2%) announces that it has struck an agreement with the FDA to modify its Nplate...

|About: Amgen Inc. (AMGN)|By:, SA News Editor

Amgen (AMGN -0.2%) announces that it has struck an agreement with the FDA to modify its Nplate treatment designed to treat an immune system disorder that attacks blood elements. "The FDA has now concluded that enrollment in a restricted distribution program is no longer necessary to prescribe or receive Nplate."